Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Treatment Adherence and Compliance 1Prostatic Neoplasms 1Pathophobia 1Orgasm 1Depression 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Cisplatin 178Paclitaxel 79Radiotherapy 76Carboplatin 70Brachytherapy 69pembrolizumab 63Bevacizumab 40Gemcitabine 28Radiation 27Topotecan 26Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 25Nivolumab 22Colposcopy 22human papillomavirus vaccine, L1 type 16, 18 21Magnetic Resonance Spectroscopy 21Drug Therapy 20atezolizumab 19Platinum 19Papillomavirus Vaccines 18Radiotherapy, Intensity-Modulated 17Docetaxel 17Taxes 16Cyclophosphamide 16Biopsy 16Early Intervention, Educational 151,2-diaminocyclohexaneplatinum II citrate 15Methods 14Blood Specimen Collection 14fludarabine 13Injections 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uterine Cervical Neoplasms × Cognitive Restructuring × Clear all
NCT04165460 2025-05-28

Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients

National Institute of Cancerología

Phase NA Enrolling by invitation
92 enrolled
Gynecologic

Treatment Adherence and Compliance, Anxiety Disorders, Uterine Cervical Neoplasms, Depression, Orgasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡